Importance Weight loss of 5% to 10% can improve type 2 diabetes and related
comorbidities. Few safe, effective weight-management drugs are currently available …

OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Background Obesity is a chronic disease with serious health consequences, but weight loss
is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like …

Background The combination of insulin and glucagon-like peptide-1 (GLP-1) receptor
agonist therapy improves glycaemic control, induces weight loss, and reduces insulin dose …

Aim To investigate the effects of liraglutide treatment on glycaemic control and adipose
tissue metabolism in overweight and obese people with type 1 diabetes (T1DM). Research …

Background The frequency of obesity has risen dramatically in recent years but only few
safe and effective drugs are currently available. We assessed the effect of liraglutide on …

OBJECTIVE To investigate whether liraglutide added to treat-to-target insulin improves
glycemic control and reduces insulin requirements and body weight in subjects with type 1 …

Aim We investigated the relationship between weight change and related factors in subjects
with type 2 diabetes mellitus (T2DM) treated with liraglutide versus comparator diabetes …

Objective Real‐world clinical effectiveness of liraglutide 3.0 mg, in combination with diet and
exercise, was investigated 4 and 6 months post initiation. Changes in absolute and percent …

Introduction In clinical trials, liraglutide has proven to be an effective drug for the treatment of
type 2 diabetes mellitus (T2DM). The real-world effectiveness of liraglutide has been …